HEALTHEQUITY, INC.
Close on Oct 19, 2026
- Market cap
- $7.82B
- P/E (TTM)
- 33.6
- Dividend yield
- –
Earnings
Next report expected Dec 2, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2027 Ended Jul 31, 2026 | Aug 27, 2026 | Before market open | $350.70M | $0.78 | $1.24 |
| Q1 FY2027 Ended Apr 30, 2026 | May 28, 2026 | After market close | $354.60M | $0.82 | $1.24 |
| Q4 FY2026 Ended Jan 31, 2026 | Feb 17, 2026 | After market close | – | – | – |
| Q3 FY2026 Ended Oct 31, 2025 | Dec 3, 2025 | After market close | $322.20M | $0.59 | $1.01 |
| Q2 FY2026 Ended Jul 31, 2025 | Sep 2, 2025 | After market close | $325.80M | $0.68 | $1.08 |
| Q1 FY2026 Ended Apr 30, 2025 | Jun 3, 2025 | After market close | $330.80M | $0.61 | $0.97 |
| Q4 FY2025 Ended Jan 31, 2025 | Mar 18, 2025 | After market close | $311.80M | $0.30 | $0.69 |
| Q3 FY2025 Ended Oct 31, 2024 | Dec 9, 2024 | After market close | $300.40M | $0.06 | $0.78 |
| Q2 FY2025 Ended Jul 31, 2024 | Sep 3, 2024 | After market close | $299.90M | $0.40 | $0.86 |
| Q1 FY2025 Ended Apr 30, 2024 | Jun 3, 2024 | After market close | $287.60M | $0.33 | $0.80 |
| Q4 FY2024 Ended Jan 31, 2024 | Mar 19, 2024 | After market close | $262.40M | $0.30 | $0.63 |
Company guidance
Outlook given with results on Aug 27, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | fiscal year ending January 31, 2027 | $628.00M to $636.00M | Raised |
| non-GAAP net income per diluted sharenon-GAAP | fiscal year ending January 31, 2027 | $4.66 to $4.73 | Maintained |
| net income per diluted shareGAAP | fiscal year ending January 31, 2027 | $2.88 to $2.96 | Raised |
| net incomeGAAP | fiscal year ending January 31, 2027 | $242.00M to $248.00M | Maintained |
| non-GAAP net incomenon-GAAP | fiscal year ending January 31, 2027 | $392.00M to $398.00M | Maintained |
| revenues | fiscal year ending January 31, 2027 | $1.41B to $1.42B | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Healthequity filed with the SEC
HealthEquity Appoints Moody’s CFO Noémie Heuland
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Appoints Sanford Health CEO Bill Gassen
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook
Results of operations · EX-99.1 to Form 8-K
HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics
Results of operations · EX-99.1 to Form 8-K
HealthEquity Announces Fiscal Year 2027 Outlook
Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports First Quarter Ended April 30, 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports Year-End Sales Metrics
Results of operations · EX-99.1 to Form 8-K
HealthEquity Announces Record Year-End HSA Sales Outlook
Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Announces Retirement of CEO Jon Kessler;
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Second Quarter Ended July 31, 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports First Quarter Ended April 30, 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Closes Acquisition of BenefitWallet HSA Portfolio
Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports Year-End Sales Metrics
Results of operations · EX-99.1 to Form 8-K
HealthEquity Announces Year-End HSA Sales Outlook;
Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Third Quarter Ended October 31, 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
BenefitWallet HSA Portfolio Moving to HealthEquity
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Second Quarter Ended July 31, 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports First Quarter Ended April 30, 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports Record HSA Sales, Asset Growth
Results of operations · EX-99.1 to Form 8-K
HealthEquity Announces Record HSA Sales Outlook,
Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Third Quarter Ended October 31, 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports Second Quarter Ended July 31, 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Expands Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports First Quarter Ended April 30, 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Releases Annual Corporate Social Responsibility Report
Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Expands Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
HealthEquity Reports Record HSA Sales, Asset Growth
Results of operations · EX-99.1 to Form 8-K
HealthEquity Announces record HSA Sales Outlook,
Regulation FD disclosure · EX-99.1 to Form 8-K
HealthEquity Reports Third Quarter Ended October 31, 2021 Financial Results
Results of operations · EX-99.1 to Form 8-K
NEWSWIRE) – November 1, 2021 - HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation's
Material agreement · Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K